Cargando…
Short-term outcome of patients with adult IgA vasculitis: a single-center experience
BACKGROUND: Follow-up data on IgA vasculitis (IgAV) in adults are scarce. We aimed to investigate the outcome of adult IgAV in a well-defined cohort. METHODS: Data from histologically proven patients diagnosed between January 2010 and July 2022 with at least a 3-month follow-up were analyzed. The fr...
Autores principales: | Hočevar, Alojzija, Ostrovršnik, Jaka, Jurčić, Vesna, Tomšič, Matija, Rotar, Žiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387581/ https://www.ncbi.nlm.nih.gov/pubmed/37529245 http://dx.doi.org/10.3389/fmed.2023.1210307 |
Ejemplares similares
-
Predicting gastrointestinal and renal involvement in adult IgA vasculitis
por: Hočevar, Alojzija, et al.
Publicado: (2019) -
IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults
por: Hočevar, Alojzija, et al.
Publicado: (2016) -
Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study
por: Kramarič, Jelka, et al.
Publicado: (2022) -
Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19”
por: Hočevar, Alojzija, et al.
Publicado: (2022) -
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
por: Kramarič, Jelka, et al.
Publicado: (2022)